News for 'biotechnology'

'It is as if secular means not to speak about religion'

'It is as if secular means not to speak about religion'

Rediff.com27 Jun 2013

Dr B Ashok, an IAS officer from Kerala, explains why he wrote a controversial article supporting the invite to Narendra Modi by a mutt in the state.

Leaders, activists come together against GM crops

Leaders, activists come together against GM crops

Rediff.com26 Jun 2013

Political leaders cutting across party lines have joined hands with the civil society to launch a nationwide campaign against GM crops and the Biotechnology Regulatory Authority of India Bill.

US keen to partner India in biotech

US keen to partner India in biotech

Rediff.com26 Jun 2003

India's biotech industry has a vast potential for bilateral cooperation with US firms for collaborative research, technology trade, licensing and distribution.\n\n\n\n

Reliance Life to shift to IPCL

Reliance Life to shift to IPCL

Rediff.com26 May 2003

'Red tape stifling India's biotech sector'

'Red tape stifling India's biotech sector'

Rediff.com15 Apr 2003

Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.

Country needs biotech policy: Kalam

Country needs biotech policy: Kalam

Rediff.com22 Mar 2003

President A P J Abdul Kalam on Saturday said the country needed a national biotech policy for tapping the full potential of the science and utilising it for economic development.

Biotech sector major thrust area: Govt

Biotech sector major thrust area: Govt

Rediff.com21 Mar 2003

Government on Friday said it was eyeing the biotechnology sector as a major thrust area and would improve regulatory mechanisms for rational promotion of genetically-modified organisms.

The inspiring story of a BPO in Rajasthan

The inspiring story of a BPO in Rajasthan

Rediff.com18 Jul 2013

Shrot Katewa from Jhunjhunu district of Rajasthan started 'Source for Change'- a rural BPO to empower the women of his village through professional training activities leading to employment. This is his story.

Biotech bug bites Ranbaxy

Biotech bug bites Ranbaxy

Rediff.com6 Feb 2003

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Rediff.com24 Nov 2020

Almost each of these companies has a different technology to show for the effectiveness against microbes.

Biotech sector set for a boom

Biotech sector set for a boom

Rediff.com24 Sep 2003

India's biotech sector is expected to grow 25-30 per cent during the current fiscal over Rs 1,830 crore revenue generated during 2002-03, according to a joint survey by the Association of Biotechnology Led Enterprises and Biospectrum.

Pharma firms in biotech thrust

Pharma firms in biotech thrust

Rediff.com14 Aug 2003

Scientists in Kashmir successfully clone Pashmina goat

Scientists in Kashmir successfully clone Pashmina goat

Rediff.com13 Mar 2012

Scientists at the Kashmir Agriculture University have produced the world's first cloned Pashmina goat.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Rediff.com10 Oct 2020

Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.

Apply for the Stanford-India Biodesign Fellowship

Apply for the Stanford-India Biodesign Fellowship

Rediff.com27 Apr 2012

Apply for the Stanford-India Biodesign Fellowship in Biomedical Technology Innovation or the S K Patil Loan Scholarships to study abroad. Read on for details

In PHOTOS: The world's first cloned pashmina goat

In PHOTOS: The world's first cloned pashmina goat

Rediff.com15 Mar 2012

Scientists at the Kashmir Agriculture University have produced the world's first cloned pashmina goat.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

BRICS: Why India must stand up for itself

BRICS: Why India must stand up for itself

Rediff.com30 Mar 2012

We have to be much more rigorous and analytical in assessing the importance of the BRICS, says Parag Khanna.

After brawl with ABVP activists, JNU student goes missing

After brawl with ABVP activists, JNU student goes missing

Rediff.com18 Oct 2016

Najeeb Ahmad, pursuing MSc in Biotechnology and resident of room 106 of Mahi/Mandavi hostel, has been missing since yesterday allegedly after an altercation with a few students on Saturday night, they added.

Biocon's accounting process comes under scanner

Biocon's accounting process comes under scanner

Rediff.com22 May 2012

Biotech company denies all charges.

How Serum and Bharat battled for COVID-19 vaccine

How Serum and Bharat battled for COVID-19 vaccine

Rediff.com23 Apr 2021

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.

Ayurveda doctor joins race for COVID-19 cure

Ayurveda doctor joins race for COVID-19 cure

Rediff.com8 May 2020

'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

PM Modi, Belgian PM Michel jointly launch Asia's biggest telescope

PM Modi, Belgian PM Michel jointly launch Asia's biggest telescope

Rediff.com30 Mar 2016

Prime Minister Narendra Modi and his Belgian counterpart Charles Michel remotely launched Asia's biggest telescope, the ARIES, built with Belgian assistance.

18 hottest technology innovators from India

18 hottest technology innovators from India

Rediff.com11 Mar 2011

Their exceptional technical contributions hold great promise to shape our future.

47% Covid victims in India aged below 60 years: Govt

47% Covid victims in India aged below 60 years: Govt

Rediff.com13 Oct 2020

"Also, 35 per cent deaths were recorded in the age group of 45-60 years, 10 per cent in the age group of 26-44 years and one per cent each in the age group of 18-25 years and below 17 years," the health secy said.

Biocon Q3 net up 9% at Rs 93 crore

Biocon Q3 net up 9% at Rs 93 crore

Rediff.com25 Jan 2013

The Bengaluru-headquartered firm had posted a net profit of Rs 84.85 crore (Rs 848.5 million) during the same period of previous fiscal.

Beware! 9 regulations that put students in a soup

Beware! 9 regulations that put students in a soup

Rediff.com10 Oct 2011

From MBBS to biotechnology, across academic and professional programmes, the regulators have consistently been betraying the trust students place in them. Read on to find out how.

CBSE puts class XII sample papers on its site

CBSE puts class XII sample papers on its site

Rediff.com15 Dec 2011

The CBSE has mounted 32 sample papers of Class XII and of 28 other examinations on its website and students can download them free.

Pfizer, Bicon scrap insulin deal

Pfizer, Bicon scrap insulin deal

Rediff.com13 Mar 2012

US-based drugmaker Pfizer and Indian biotechnology major Bicon today said they have agreed to end their alliance to sell insulin and insulin analog products made by the Indian company.

Top science careers to pursue after class 12

Top science careers to pursue after class 12

Rediff.com26 May 2016

Think beyond engineering and medicine.

Rahul Gandhi to visit US to talk about artificial intelligence

Rahul Gandhi to visit US to talk about artificial intelligence

Rediff.com5 Sep 2017

The sources said Gandhi wants India to lead in the niche area which comes after software development.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

No signs of Covid curve flattening, cases to peak in Jul-Aug

No signs of Covid curve flattening, cases to peak in Jul-Aug

Rediff.com18 May 2020

'We don't know how complicated things will get with the onset of the monsoon.'

Can Indians live without Chinese imports?

Can Indians live without Chinese imports?

Rediff.com1 Jul 2020

'India imports 70 per cent of its bulk drugs from China. Are we going to live without antibiotics?' asks Debashis Basu.

EXCLUSIVE: Kiran Mazumdar-Shaw on innovation, entrepreneurship

EXCLUSIVE: Kiran Mazumdar-Shaw on innovation, entrepreneurship

Rediff.com10 Aug 2011

The story of Kiran Mazumdar-Shaw is one of grit, self confidence and courage. If today she is one of the most successful entrepreneurs in the world, it is because of her determination.